These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27733317)

  • 1. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes.
    Zhang WJ; Xia WL; Pan HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation.
    Xia VW; Ghobrial RM; Du B; Chen T; Hu KQ; Hiatt JR; Busuttil RW; Steadman RH
    Anesth Analg; 2007 Sep; 105(3):780-5. PubMed ID: 17717240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.
    Pan X; Apinyachon W; Xia W; Hong JC; Busuttil RW; Steadman RH; Xia VW
    Liver Transpl; 2014 Jul; 20(7):823-30. PubMed ID: 24711100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative Events in Liver Transplantation Using Donation After Circulatory Death Donors.
    Chadha RM; Croome KP; Aniskevich S; Pai SL; Nguyen J; Burns J; Perry D; Taner CB
    Liver Transpl; 2019 Dec; 25(12):1833-1840. PubMed ID: 31539458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis.
    Croome KP; Mathur AK; Mao S; Aqel B; Piatt J; Senada P; Heimbach JK; Moss A; Rosen CB; Taner CB
    Am J Transplant; 2020 Sep; 20(9):2449-2456. PubMed ID: 32216008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled DCD Liver Transplantation Is Not Associated With Increased Hyperfibrinolysis and Blood Loss After Graft Reperfusion.
    Karangwa SA; Adelmeijer J; Burgerhof JGM; Lisman T; de Meijer VE; de Kleine RH; Reyntjens KMEM; van den Berg AP; Porte RJ; de Boer MT
    Transplantation; 2022 Feb; 106(2):308-317. PubMed ID: 33606482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient hyperglycemia during liver transplantation does not affect the early graft function.
    Blasi A; Beltran J; Martin N; Martinez-Pallí G; Lozano JJ; Balust J; Torrents A; Taura P
    Ann Hepatol; 2015; 14(5):675-87. PubMed ID: 26256896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
    Taner CB; Bulatao IG; Willingham DL; Perry DK; Sibulesky L; Pungpapong S; Aranda-Michel J; Keaveny AP; Kramer DJ; Nguyen JH
    Liver Transpl; 2012 Jan; 18(1):100-11. PubMed ID: 21837741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
    Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
    Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Risk Factors in the Development of Intraoperative Hyperkalemia in Adult Living Donor Liver Transplantation.
    Juang SE; Huang CE; Chen CL; Wang CH; Huang CJ; Cheng KW; Wu SC; Shih TH; Yang SC; Wong ZW; Jawan B; Lee YE
    Transplant Proc; 2016 May; 48(4):1022-4. PubMed ID: 27320547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation.
    Compagnon P; Levesque E; Hentati H; Disabato M; Calderaro J; Feray C; Corlu A; Cohen JL; Ben Mosbah I; Azoulay D
    Transplantation; 2017 Jul; 101(7):e205-e213. PubMed ID: 28403128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
    Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
    Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
    Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
    Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Gehrau RC; Mas VR; Dumur CI; Suh JL; Sharma AK; Cathro HP; Maluf DG
    Transplantation; 2015 Dec; 99(12):2523-33. PubMed ID: 26285018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Biliary Strictures After Liver Transplantation Among Recipients of DCD (Donation After Cardiac Death) Grafts.
    Kohli DR; Harrison ME; Adike AO; El Kurdi B; Fukami N; Faigel DO; Pannala R; Moss AA; Aqel BA
    Dig Dis Sci; 2019 Jul; 64(7):2024-2030. PubMed ID: 30604376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated effluent potassium concentrations predict the development of postreperfusion hyperkalemia in deceased liver transplantation: a retrospective cohort study.
    Zhang L; Xue FS; Tian M; Zhu ZJ
    BMC Anesthesiol; 2022 May; 22(1):161. PubMed ID: 35614393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.